You are here
The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.
SBC: Binergy Scientific Inc. Topic: CBD14101
A chemical threat agent mode of action is often initiated through a selective interaction with a biological molecule or structure. The binding event mimics normal cellular processes, but then overruns natural control mechanisms leading to toxic and lethal effects. The native binding specificity is used to design sensor recognition elements that outperform conventional antibody-based biosensors. Ou ...SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: Keratin Biosciences Inc. Topic: A14048
The Phase I and Phase II projects that are the basis for this Phase II enhancement proposal tested the feasibility of releasing opiate compounds from a topical wound dressing for burn pain relief and treatment. This project culminated with a regulatory sSBIR Phase II 2019 Department of DefenseDefense Health Agency
SBC: Zymeron Corporation Topic: CBD161003
The skin is the first line of defense against chemical warfare agents including nerve agents and toxic industrial chemicals, providing a possible barrier or delay to systemic distribution. Some chemicals also can act directly on the skin including the vesicants sulfur mustard and lewisite. Early and rapid skin decontamination is extremely important following exposure to CWAs and TICs because it de ...SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense